Fraguas D, Díaz-Caneja CM, Pina-Camacho L, Moreno C,
Durán-Cutilla M, Ayora M, González-Vioque E, de Matteis M, Hendren RL, Arango C,
Parellada M. Dietary Interventions for Autism Spectrum Disorder: A Meta-analysis.
Pediatrics. 2019 Nov;144(5).
CONTEXT: Dietary interventions such as restrictive diets or
supplements are common treatments for young people with autism spectrum
disorder (ASD). Evidence for the efficacy of these interventions is still
controversial.
OBJECTIVE: To assess the efficacy of specific dietary
interventions on symptoms, functions, and clinical domains in subjects with ASD
by using a meta-analytic approach.
DATA SOURCES: Ovid Medline, PsycINFO, Embase databases.
STUDY SELECTION: We selected placebo-controlled,
double-blind, randomized clinical trials assessing the efficacy of dietary
interventions in ASD published from database inception through September 2017.
DATA EXTRACTION: Outcome variables were subsumed under 4
clinical domains and 17 symptoms and/or functions groups. Hedges’ adjusted g
values were used as estimates of the effect size of each dietary intervention
relative to placebo.
RESULTS: In this meta-analysis, we examined 27 double-blind,
randomized clinical trials, including 1028 patients with ASD: 542 in the
intervention arms and 486 in the placebo arms. Participant-weighted average age
was 7.1 years. Participant-weighted average intervention duration was 10.6
weeks. Dietary supplementation (including omega-3, vitamin supplementation,
and/or other supplementation), omega-3 supplementation, and vitamin
supplementation were more efficacious than the placebo at improving several
symptoms, functions, and clinical domains. Effect sizes were small (mean
Hedges’ g for significant analyses was 0.31), with low statistical
heterogeneity and low risk of publication bias.
LIMITATIONS: Methodologic heterogeneity among the studies in
terms of the intervention, clinical measures and outcomes, and sample
characteristics.
CONCLUSIONS: This meta-analysis does not support nonspecific
dietary interventions as treatment of ASD but suggests a potential role for
some specific dietary interventions in the management of some symptoms,
functions, and clinical domains in patients with ASD.
Courtesy of:
https://www.mdlinx.com/journal-summaries/dietary-interventions-asd-autism-spectrum-disorder/2019/11/07/7584074?spec=neurology
From the paper
Meta-analyses revealed the following:
Dietary supplementation (omega-3, vitamin supplementation,
and/or other supplementation) was more effective than placebo in treating the
following symptoms and/or functions groups: anxiety and/or affect, autistic
general psychopathology, behavioral problems and impulsivity, global severity,
hyperactivity and irritability, language (general), and social-autistic and
stereotypies, restricted and repetitive behaviors. Dietary
supplementation (omega-3, vitamin supplementation, and/or other supplementation)
was more effective than placebo in treating the following clinical domains:
core symptoms, associated symptoms, autism global, and clinical global
impression.
Omega-3 supplementation was more effective than placebo in
treating the following symptoms and/or functions groups: language (general) and
social-autistic (see Table 2). Omega-3 supplementation was more effective than
placebo in treating the following clinical domains: core symptoms and
associated symptoms.
Vitamin supplementation was more effective than placebo in
treating the following symptoms and/or functions groups: global severity,
language (general), stereotypies, restricted and repetitive behaviors,
behavioral problems and impulsivity, and hyperactivity and irritability. Vitamin supplementation was more effective than placebo in treating
the following clinical domains: core symptoms, associated symptoms, and
clinical global impression
.
For all types of dietary intervention, significant
meta-analyses revealed small effect size relative to placebo, low statistical
heterogeneity, and low risk of publication bias.
No comments:
Post a Comment